Annual and Special Reporting by the Firm
Auditor Reporting of Certain Audit Participants
Form | Filed Date | Issuer Name | Audit Report Date | Engagement Partner | |
Form AP
|
09/13/2024
|
Amcor plc
|
08/16/2024
|
D'Angelo, Adam Michael
|
|
Form AP
|
06/28/2024
|
Global Blue Group Holding AG
|
06/05/2024
|
Johnson, Colin
|
|
Form AP/A
|
05/30/2024
|
Amcor plc
|
08/17/2023
|
Kartscher, Peter
|
|
Form AP
|
09/13/2023
|
Amcor plc
|
08/17/2023
|
Kartscher, Peter
|
|
Form AP
|
05/29/2024
|
NLS Pharmaceutics Ltd
|
05/15/2024
|
Rossi, Bruno
|
|
Form AP
|
04/24/2024
|
Credit Suisse AG
|
03/28/2024
|
Falconer, Matthew George
|
|
Form AP
|
04/17/2024
|
Oculis Holding AG
|
03/19/2024
|
Foley, Michael
|
|
Form AP
|
04/08/2024
|
ADC Therapeutics SA
|
03/13/2024
|
Schulthess, Luc
|
|
Form AP
|
04/03/2024
|
AC Immune SA
|
03/14/2024
|
Rossi, Bruno
|
|
Form AP
|
04/03/2024
|
On Holding AG
|
03/12/2024
|
Balkanyi, Patrick
|
|
Form AP
|
03/20/2024
|
SOPHiA GENETICS SA
|
03/05/2024
|
Foley, Michael
|
|
Form AP
|
03/08/2024
|
Philip Morris International Inc.
|
02/08/2024
|
Clark, Mary Catherine
|
|
Form AP/A
|
03/08/2024
|
Philip Morris International Inc.
|
02/10/2023
|
Mueller, Chad F
|
|
Form AP
|
03/16/2023
|
Philip Morris International Inc.
|
02/10/2023
|
Mueller, Chad F
|
|
Form AP
|
03/06/2024
|
Novartis AG
|
02/01/2022
|
Benz, Claudia
|
|
Form AP/A
|
03/06/2024
|
Novartis AG
|
02/01/2022
|
Benz, Claudia
|
|
Form AP
|
03/03/2022
|
Novartis AG
|
02/01/2022
|
Benz, Claudia
|
|
Form AP
|
07/14/2023
|
Global Blue Group Holding AG
|
06/28/2023
|
Johnson, Colin
|
|
Form AP
|
05/26/2023
|
NLS Pharmaceutics Ltd
|
05/05/2023
|
Balkanyi, Patrick
|
|
Form AP
|
04/21/2023
|
ObsEva SA
|
03/31/2023
|
Schulthess, Luc
|
|
Form AP
|
04/20/2023
|
Oculis Holding AG
|
03/28/2023
|
Foley, Michael
|
|
Form AP
|
04/19/2023
|
On Holding AG
|
03/21/2023
|
Balkanyi, Patrick
|
|
Form AP
|
04/18/2023
|
AC Immune SA
|
03/16/2023
|
Foley, Michael
|
|
|
Currently Subject to Board Determination Under the Holding Foreign Companies Accountable Act?
|